SEC Form 4 · accession 0001643086-17-000001

Evolent Health, Inc. · EVH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Mar 24, 2017

Accepted (ET)

Mar 27, 2017 · 5:11 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001628908

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Mar 24, 2017	M	5,001	$3.84	A	137,414	D
Clsss A Common Stock^F2	Mar 24, 2017	S	5,001	$22.50	D	132,413	D
Class A Common Stock	Mar 24, 2017	S	2,033	$22.50	D	130,380	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class A Common Stock Option (right to buy)^F3	$3.84	Mar 24, 2017	M	5,001	D	—	Oct 22, 2024	Class A Common Stock	5,001	273,794	D

F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016.
F2The shares were sold in a multiple transactions, all at a price of $22.50. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction covered by this footnote.
F3The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on the day following the first anniversary of the grant date.